Home›Stock Screener›Nexus Surgical & Medicare›Financial Statements

Nexus Surgical & Medicare Complete Financial Statements

12 Years of Data
2026 - 2015

In FYNone, Nexus Surgical & Medicare (NEXUSSURGL) reported revenue ₹9 Cr, net profit ₹1 Cr and EPS ₹1.40, with a net profit margin of 12.5% and ROE of 50.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 12.50% 2026 data
EBITDA Margin 12.50% 2026 data
Operating Margin 12.00% 2026 data
Return on Assets 25.00% 2026 data
Return on Equity 50.00% 2026 data

Balance Sheet Ratios

Equity Ratio 50.00% 2026 data
Asset Turnover 2.00 2026 data

NEXUSSURGL Revenue, Net Profit & EBITDA — Year-on-Year Growth

NEXUSSURGL YoY (March 2026 vs Period) — revenue +12.5%, expenses +14.3%. Compare with NEXUSSURGL stock valuation models to assess whether the stock is under or overvalued.

Revenue Growth
+12.5%
Year-over-Year
Expense Growth
+14.3%
Year-over-Year
Assets Growth
+100.0%
Year-over-Year
Equity Growth
+100.0%
Year-over-Year

NEXUSSURGL Income Statement — Revenue, EBITDA & Net Profit

Nexus Surgical & Medicare revenue ₹9 Cr, EBITDA ₹1 Cr, net profit ₹1 Cr, EPS ₹1.40 (None) — net profit margin 12.5%. For live price, earnings ratios and company overview, see Nexus Surgical & Medicare stock price NSE.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 9 8 6 4 2 2 4 2 2 1 0 0 0
Expenses 8 7 5 3 1 2 4 2 2 1 1 0 0
EBITDA 1 1 1 0 0 0 0 0 0 0 0 0 0
Operating Profit Margin % 13.00% 12.00% 12.00% 8.00% 14.00% 15.00% 4.00% 4.00% -8.00% -39.00% -62.00% 23.00% 50.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 1 0 0 0 0 -5 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 1 0 0 0 0 -5 0 0 0 0 0
Earnings Per Share (₹) 1.40 1.35 0.91 0.39 0.31 0.53 0.28 -9.68 -0.20 -0.60 -0.35 0.09 0.27

NEXUSSURGL Balance Sheet — Assets, Liabilities & Shareholders' Equity

NEXUSSURGL total assets ₹4 Cr, total equity ₹2 Cr, total liabilities ₹ Cr (2026) — ROE 50.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 4 2 2 1 2 1 0 6 6 6 6 6
Current Assets 4 2 2 1 2 1 0 0 0 1 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0 0 5 5 5 5 5
Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 4 2 2 1 2 1 0 0 0 1 0 0
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 2 1 1 0 0 0 0 5 5 6 6 6
Share Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves & Surplus -4 -4 -5 -5 -5 -6 -6 0 0 0 0 0

NEXUSSURGL Cash Flow Statement — Operating, Investing & Financing

Nexus Surgical & Medicare operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 0 0 0 1 0 0 0 0 0 0 0 0
Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0
Financing Activities 0 0 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 1 0 0 0 0 0 0 0 0